This summary was created by AI, based on 1 opinions in the last 12 months.
Chemed Corporation, known for its strong performance in the hospice business, is experiencing significant growth, with double-digit expansion reported by experts. This growth reflects not only the increasing demand for hospice services but also the company's ability to capitalize on this trend effectively. The expert reviews indicate a positive outlook for Chemed, highlighting its strategic position within the industry and the potential for sustained profitability. Overall, Chemed appears to be well-prepared to navigate the changing healthcare landscape, making it a strong candidate for investors looking for reliable growth opportunities in the sector.
They have been around for over 100 years. They survived the depression. They have interests in hospices and cleaning. They have dental supply as well. They have a long history of raising dividends and buybacks. He'd like to see it lower before buying. (Analysts’ price target is $595.00)
Chemed Corporation is a American stock, trading under the symbol CHE-N on the New York Stock Exchange (CHE). It is usually referred to as NYSE:CHE or CHE-N
In the last year, 1 stock analyst published opinions about CHE-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Chemed Corporation.
Chemed Corporation was recommended as a Top Pick by on . Read the latest stock experts ratings for Chemed Corporation.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Chemed Corporation In the last year. It is a trending stock that is worth watching.
On 2025-02-21, Chemed Corporation (CHE-N) stock closed at a price of $542.93.
She added more. The hospice business is growing double-digits.